Research Peptides
RESEARCH USE ONLY
Research Peptides
RESEARCH USE ONLY
| Ingredients | Semaglutide (SEMAGLUTIDE) — GLP-1 receptor agonist analog, Aib8 / Arg34 / C18 diacid side chain |
|---|---|
| Storage | Store refrigerated at 2-8°C, do not freeze, protect from light. |
| Shelf life | 24 months |
| SKU | Content - Spec | Pack | Price | Stock |
|---|---|---|---|---|
| SM5 | 5mg | 10 vials | $49.00 | In stock |
| SM10 | 10mg | 10 vials | $59.00 | In stock |
| SM15 | 15mg | 10 vials | $69.00 | In stock |
| SM20 | 20mg | 10 vials | $79.00 | In stock |
| SM30 | 30mg | 10 vials | $119.00 | In stock |
| SM40 | 40mg | 10 vials | $139.00 | In stock |
| SM50 | 50mg | 10 vials | $169.00 | In stock |
Research reagents are for laboratory and in-vitro research only. Not for human use.
Research reagents are not supplied as medicines and must not be used for diagnosis, treatment, prevention, clinical procedures or self-medication. Product information must not be used as administration or dosing guidance.
For accessories and consumables, follow their own specifications and documented intended use.
Semaglutide is a GLP-1 receptor agonist used for fat loss and blood glucose control. It achieves weight management by suppressing appetite and delaying gastric emptying.
Suppresses appetite, reduces calorie intake; delays gastric emptying, increases satiety; promotes insulin secretion, lowers blood glucose; improves insulin sensitivity; effectively reduces body weight, decreases waist circumference.
Subcutaneous injection once weekly. Starting dose: 0.25 mg for 4 weeks; then increase every 4 weeks, maintenance dose: 2.4 mg (for fat loss). Specific cycle follow doctor's advice. Reconstitute before use (if lyophilized powder).
Adults with obesity or overweight accompanied by weight-related complications (e.g., hypertension, type 2 diabetes, hyperlipidemia); patients with type 2 diabetes requiring weight management.